Ranked 24th in the Best "Multinational Large" Workplace
READING, England--(BUSINESS WIRE)--
announced today that it has been recognized as one of Europe's
Best Workplaces by the Great Place to Work® Institute,
finishing in 24th place in the Best "Multinational Large"
Workplace category. Quintiles was also recognized this year in several
individual European countries including Germany, Italy, Poland, Spain
and the United Kingdom.
The Great Place to Work Institute annual ranking is the most
comprehensive study in organizational culture in the world. More than
2,330 companies representing over 1.5 million employees participated in
the 2013-14 Best Workplaces study in Europe. This year's recognition
marks Quintiles' fourth appearance on the European Great Places to Work
Quintiles senior vice president integrated site services, European
headquarters, Lindy Jones said, "This award represents the company's
commitment to providing a positive work environment that fosters
passionate and engaged employees who are dedicated to excellent customer
service and helping to improve the lives of patients worldwide. We are
incredibly proud of our teams across Europe, for their contribution for
making Quintiles a Great Place to Work."
Great Place to Work launched the first Best Companies to Work For
list in conjunction with Fortune magazine in the United States
and Exame in Brazil more than 20 years ago. Great Place to Work
now recognises workplaces in nearly 50 countries.
"The Great Workplace Era is a time when all people can expect to work
for an organisation where they trust their leaders, enjoy their
colleagues and take pride in what they do. A time, in other words, when
workplaces make the world better," says China Gorman, global CEO of
Great Place to Work. "This era is arriving in Europe and other parts of
the globe. And it's good news for everyone."
Quintiles (NYSE:Q) is the world's largest provider of biopharmaceutical
development and commercial outsourcing services with a network of more
than 29,000 employees conducting business in approximately 100
countries. We helped develop or commercialize all of 2013's top-100
best-selling drugs on the market. Quintiles applies the breadth and
depth of our service offerings along with extensive therapeutic,
scientific and analytics expertise to help our customers navigate an
increasingly complex healthcare environment as they seek to improve
efficiency and effectiveness in the delivery of better healthcare
outcomes. To learn more about Quintiles, please visit www.quintiles.com